NCT06785285

Brief Summary

The quality of the spinal anesthesia has beenreported to be improved by the addition of opioids (such as morphine, fentanyl and sufentanil) and other drugs (such as dexmedetomidine, clonidine, magnesium sulfate (Mg), neostigmine, ketamine, and midazolam). Opioids such as fentanyl in combination with bupivacaine improvesthe quality of intraoperative and early postoperative subarachnoid block. Although, fentanylensures superior quality of analgesia, it is associated with many side effects. This has directed theresearch toward the use of newer and betteradjuvants for spinal anesthesia such as clonidineand dexmedetomidine

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 27, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 21, 2025

Completed
Last Updated

January 21, 2025

Status Verified

March 1, 2024

Enrollment Period

7 months

First QC Date

November 27, 2024

Last Update Submit

January 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Relief

    Patient's pain score will be assessed using visual analogue scale (VAS); scored from 0-10 (where 0=no pain and 10=the worst pain imaginable) during the recovery room (T0) and at one, three, and six hours (T1, T3, and T6) in the postoperative period.

    from 0 hours to 6 hours after the procedure

Study Arms (2)

Group A

ACTIVE COMPARATOR

About 30 patients received Dexmeditomidine 5 ug and added to it 10 mg hyperbaric bupivicaine 0.5 % .

Drug: Dexmedetomidine

Group B

ACTIVE COMPARATOR

About 30 patients received fentanyl 25 ug and added to it 10 mg hyperbaric bupivicaine 0.5 % .

Drug: Dexmedetomidine

Interventions

To compare the effects of fentanyl and dexmedetomidine when used as adjuvants to intrathecal bupivacaine in elective cesarean section, assessing their impact on the onset and duration of spinal anesthesia, quality of analgesia, hemodynamic stability, incidence of side effects, and neonatal outcomes

Also known as: fentanyl 25 ug
Group AGroup B

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women in the childbearing period
  • aged 18 to 40 years
  • Gestational age ≥37 weeks of pregnancy
  • ASA I and II candidates for elective cesarean section under spinal anesthesia.

You may not qualify if:

  • The patients with emergency conditions,
  • Contraindication of spinal anesthesia,
  • History of valvular heart disease,
  • History of allergy or sensitivity to applied drugs and
  • Patients with placenta previa
  • Failed blockade or need for induction of general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

Location

MeSH Terms

Interventions

DexmedetomidineFentanyl

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPiperidines

Study Officials

  • Nehal samir esmail, Lecturer

    Sohag University, Faculty of medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia, intensive care and pain management Faculty of Medicine

Study Record Dates

First Submitted

November 27, 2024

First Posted

January 21, 2025

Study Start

March 1, 2024

Primary Completion

October 1, 2024

Study Completion

October 10, 2024

Last Updated

January 21, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations